News

Over 40% of patients asking for an advertised drug get it


 

References

About 28% of patients surveyed say that they have talked to a physician about a prescription drug they saw advertised, and 44% of those patients report that they were given the drug they asked about, according to a Kaiser Family Foundation Health Tracking Poll conducted Oct. 14-20.

About 54% say that their physicians recommended behavior or lifestyle changes after being asked about a drug the patient had seen advertised, while 49% of patients say that the physician recommended a different prescription drug and 39% say that the physician recommended an over-the-counter drug, Kaiser reported.

The results were similar to a Health Tracking Poll conducted in March of 2008, when 32% of patients had talked with their physicians about a drug they had seen advertised. Of those patients, 57% had physicians who recommended lifestyle or behavior changes, 54% recommended a different prescription drug, 44% recommended the drug the patient asked about, and 30% recommended an OTC drug.

The 2015 poll was conducted by phone among a nationally representative sample of 1,203 adults living in the United States.

rfranki@frontlinemedcom.com

Recommended Reading

CMS seeks input to develop SGR replacement regulations
MDedge Hematology and Oncology
Half of uninsured patients are eligible for Medicaid or ACA coverage
MDedge Hematology and Oncology
Survey: Medicaid pay holds steady in states
MDedge Hematology and Oncology
HHS: Remaining uninsured worry about costs of coverage
MDedge Hematology and Oncology
PQRS informal review period opens; closes Nov. 9
MDedge Hematology and Oncology
Responding to online physician review sites
MDedge Hematology and Oncology
Delayed diagnosis tops breast cancer malpractice claims
MDedge Hematology and Oncology
Malpractice premiums flat in 2015, but changes could be ahead
MDedge Hematology and Oncology
ACA insurance networks lack specialist coverage
MDedge Hematology and Oncology
Healthcare.gov: Premiums to jump in 8 states
MDedge Hematology and Oncology